Stoke Therapeutics Inc (NASDAQ:STOK)

12.95
Delayed Data
As of Jun 28
 -0.47 / -3.50%
Today’s Change
9.55
Today|||52-Week Range
35.73
-46.02%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$533.0M

Company Description

Stoke Therapeutics, Inc. is a biotechnology company, which engages in the research and development of treatments for genetic diseases. It offers a wide range of relevant tissues including the central nervous system, eye, kidney, and liver. The company was founded by Isabel Aznarez and Adrian R. Krainer in June 2014 and is headquartered in Bedford, MA.

Contact Information

Stoke Therapeutics, Inc.
45 Wiggins Avenue
Bedford Massachusetts 01730
P:(781) 430-8200
Investor Relations:

Employees

Shareholders

Individual stakeholders96.09%
Other institutional45.15%
Mutual fund holders21.46%

Top Executives

Edward M. KayeChief Executive Officer & Director
Huw M. NashChief Operating & Business Officer
Stephen J. TulipanoChief Financial Officer
Barry S. TichoChief Medical Officer
Gene LiauChief Scientific Officer